Symbol="CRDL"
AssetType="Common Stock"
Name="Cardiol Therapeutics Inc Class A"
Description="Cardiol Therapeutics Inc., a clinical-phase biotechnology company, focuses on the research and development of anti-inflammatory therapies for the treatment of cardiovascular diseases (CVD). The company is headquartered in Oakville, Canada."
CIK="1702123"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="602-2265 UPPER MIDDLE ROAD EAST, OAKVILLE, ON, CA"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="75067000"
EBITDA="-39159128"
PERatio="None"
PEGRatio="None"
BookValue="0.711"
DividendPerShare="0"
DividendYield="0"
EPS="-0.38"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.372"
ReturnOnEquityTTM="-0.506"
RevenueTTM="0"
GrossProfitTTM="78760"
DilutedEPSTTM="-0.38"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="4.48"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="1069.35"
PriceToBookRatio="1.056"
EVToRevenue="178.81"
EVToEBITDA="0.0181"
Beta="0.912"
num_52WeekHigh="1.39"
num_52WeekLow="0.45"
num_50DayMovingAverage="0.837"
num_200DayMovingAverage="0.645"
SharesOutstanding="64098000"
DividendDate="None"
ExDividendDate="None"
symbol="CRDL"
open="1.10"
high="1.24"
low="1.08"
price="1.16"
volume="501939.00"
latest_trading_day="2023-08-03"
previous_close="1.07"
change="0.09"
change_percent="8.4112%"
aroon_positive_momentum_days="70"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Trending Low"
value_analysis="Bearish Trend"
Aroon_change="FALSE"
Aroon_momentum="70"
Volume_recent_avg="143577"
Change_recent_avg="0.01"
Delta_recent_avg="0.06"
Variance_recent_avg="0.03"
Change_ratio_recent_avg="0.43"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="70"
Aroon_momentum_negative="30"
image_negative_thumbnail_id_1="1163"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0197.jpeg"
image_negative_thumbnail_id_2="1093"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0126.jpeg"
image_neutral_thumbnail_id_1="531"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0068.jpeg"
image_neutral_thumbnail_id_2="569"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0030.jpeg"
image_positive_thumbnail_id_1="671"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0037.jpeg"
image_positive_thumbnail_id_2="957"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0119.jpeg"
image_professor_thumbnail_id_1="1183"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0017.jpeg"
image_professor_thumbnail_id_2="1204"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0038.jpeg"
